Cosela 300 mg Injection
RxNorm 2479710
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2479710 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cosela 300 mg Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Cosela 300 mg (as trilaciclib dihydrochloride 349 mg) Injection
(Atom ID: 12540652)
PSNPrescribable
Prescribable Name (PSN):
Cosela 300 mg Injection
(Atom ID: 12540650)
SYPrescribable
Synonym (SY):
Cosela 300 mg Injection
(Atom ID: 12540651)
SBDPrescribable
Semantic Branded Drug (SBD):
Trilaciclib 300 mg Injection [Cosela]
(Atom ID: 12540649)
Patient Education
Trilaciclib Injection
Trilaciclib injection is used to decrease the risk of myelosuppression (a decrease in red blood cells, white blood cells, and platelets) from certain chemotherapy medications in adults with small cell lung cancer (SCLC). Trilaciclib is in a class of medications called kinase inhibitors. It works by blocking the action of certain substances in the body to protect the cells in the bone marrow and immune system from damage during chemotherapy.
[Learn More]
* Please review the disclaimer below.